Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$1.79 - $2.9 $102,518 - $166,091
-57,273 Reduced 10.55%
485,768 $1.19 Million
Q1 2023

May 11, 2023

SELL
$2.65 - $3.81 $31,140 - $44,771
-11,751 Reduced 2.12%
543,041 $1.61 Million
Q4 2022

Jan 27, 2023

SELL
$3.38 - $4.22 $59,386 - $74,145
-17,570 Reduced 3.07%
554,792 $0
Q3 2022

Nov 01, 2022

BUY
$3.43 - $5.83 $18,865 - $32,065
5,500 Added 0.97%
572,362 $2.06 Million
Q2 2022

Aug 08, 2022

BUY
$4.41 - $5.69 $81,073 - $104,604
18,384 Added 3.35%
566,862 $3 Million
Q1 2022

May 26, 2022

BUY
$4.81 - $6.99 $771,254 - $1.12 Million
160,344 Added 41.31%
548,478 $3.01 Million
Q1 2022

May 05, 2022

SELL
$4.81 - $6.99 $763,077 - $1.11 Million
-158,644 Reduced 29.01%
388,134 $2.13 Million
Q4 2021

Feb 14, 2022

BUY
$5.97 - $7.93 $971,307 - $1.29 Million
162,698 Added 42.36%
546,778 $3.72 Million
Q3 2021

Nov 09, 2021

SELL
$4.79 - $6.68 $8,166 - $11,389
-1,705 Reduced 0.44%
384,080 $2.34 Million
Q2 2021

Jul 29, 2021

SELL
$5.35 - $6.35 $76,328 - $90,595
-14,267 Reduced 3.57%
385,785 $2.28 Million
Q1 2021

May 14, 2021

BUY
$5.68 - $7.87 $511,643 - $708,913
90,078 Added 29.06%
400,052 $2.4 Million
Q4 2020

Feb 16, 2021

SELL
$5.25 - $8.56 $70,308 - $114,635
-13,392 Reduced 4.14%
309,974 $2.15 Million
Q3 2020

Nov 16, 2020

BUY
$5.78 - $7.47 $170,475 - $220,320
29,494 Added 10.04%
323,366 $2.02 Million
Q2 2020

Aug 14, 2020

SELL
$4.5 - $7.02 $330,759 - $515,984
-73,502 Reduced 20.01%
293,872 $1.94 Million
Q1 2020

May 15, 2020

BUY
$2.87 - $5.49 $1.05 Million - $2.02 Million
367,374 New
367,374 $1.71 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $321M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.